Prescription rate of erythropoietin-stimulating agents is low for patients with renal impairment under non-nephrology care in a tertiary-level academic medical center in Japan.
Naoki OkamotoDaijo InagumaHiroki HayashiAkira KosekiToshiya IwamoriMichiharu KudoYukio YuzawaPublished in: Clinical and experimental nephrology (2022)
Treatment for anemia has not been sufficiently performed in patients with renal impairment under non-nephrology care in a real-world clinical setting.